JP Morgan Private Capital, JP Morgan’s venture capital and growth equity investment team has held the final close of 270 Life Sciences Private Capital Fund I, above its $500m target.
LSPCF received commitments from institutional allocators, strategic corporate partners, family offices and HNWIs across North America, Europe, the Middle East and Asia, as well as JPMorgan Chase & Co. The fund close was led by CIO Stephen Squinto and Managing Partner Gaurav Gupta.
LSPCF invests in private biotechnology companies spanning cardiometabolic disease, oncology, immunology and genetic medicines.
Source:Private Equity Wire
Can’t stop reading? Read more
Bansk Group acquires majority stake in fast-growing skincare brand BYOMA
Bansk Group acquires majority stake in fast-growing skincare brand BYOMA Bansk Group has agreed to...
Ares prepares €1.5bn continuation vehicle for legacy European loans
Ares prepares €1.5bn continuation vehicle for legacy European loans Ares Management is planning a...
TPG to acquire GE Vernova’s Proficy software unit in $600m deal
TPG to acquire GE Vernova’s Proficy software unit in $600m deal TPG has agreed to acquire Proficy,...
